Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tedizolid Neuropathies

NCT07143240 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tedizolid Neuropathies
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
March 1, 2025
Completion date
May 1, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients developing optic or peripheral neuropathy, while receiving tedizolid therapy between july 2019 and december 2024